4.7 Article

Cigarette smoking is associated with adverse survival among women with ovarian cancer: Results from a pooled analysis of 19 studies

Journal

INTERNATIONAL JOURNAL OF CANCER
Volume 140, Issue 11, Pages 2422-2435

Publisher

WILEY
DOI: 10.1002/ijc.30600

Keywords

cigarette smoking; ovarian cancer; survival; pooled analysis

Categories

Funding

  1. Ovarian Cancer Association Consortium
  2. European Commission's Seventh Framework Programme [223175 (HEALTH-F2-2009-223175)]
  3. National Institutes of Health [R01 CA074850, R01 CA080742, R01 CA112523, R01 CA87538, R01 CA58598, N01 CN55424, N01 PC 67001, MO1-RR000056, R01 CA61107, R01 CA122443, P30 CA15083, P50 CA136393, R01 CA76016, R01 CA54419, P50 CA105009, P30 CA072720]
  4. Danish Cancer Society [94 222 52]
  5. Mermaid 1 (MAL)
  6. Mermaid 3 (MAL)
  7. U.S. Army Medical Research and Materiel Command [DAMD17-01-1-0729]
  8. National Health AMP
  9. Medical Research Council of Australia [199600, 400281]
  10. Cancer Council of New South Wales
  11. Cancer Council of Victoria
  12. Cancer Council of Queensland
  13. Cancer Council of South Australia
  14. Cancer Council of Tasmania
  15. Cancer Foundation of Western Australia
  16. German Federal Ministry of Education and Research [01GB9401]
  17. German Cancer Research Center (GER)
  18. US Army Medical Research and Material Command [DAMD17-02-1-0669, DAMD17-02-1-0666, W81XWH-10-1-02802, DAMD17-98-1-8659]
  19. Ministry of Education, Science, Sports, Culture and Technology of Japan
  20. Ministry of Health, Labour and Welfare of Japan
  21. Takeda Science Foundation
  22. Mayo Foundation
  23. Minnesota Ovarian Cancer Alliance
  24. Fred C. and Katherine B. Andersen Foundation
  25. Cancer Institute of New Jersey
  26. National Cancer Institute
  27. Cancer Research UK [C490/A10119, C490/A10124]
  28. American Cancer Society [CRTG-00-196-01-CCE]
  29. Celma Mastry Ovarian Cancer Foundation
  30. Lon V Smith Foundation [LVS-39420]
  31. Cancer Research UK
  32. Eve Appeal
  33. OAK Foundation
  34. California Cancer Research Program [00-01389V-20170, N01 CN025403, R03 CA113148, R03 CA115195]
  35. US National Cancer Institute [P01 CA17054, K07-CA80668, P50-CA159981]
  36. Center for Disease Control (The New Jersey State Cancer Registry) [5U58DP003931-02]
  37. National Cancer Institute's Surveillance, Epidemiology, and End Results Program [HHSN 261201300021I, N01PC-2013-00021]
  38. Department of Health
  39. Abcodia Ltd, a UCL spin-out company with an interest in biomarkers and commercial rights of ROCA used in ovarian cancer screening
  40. The National Institutes of Health [K07 CA095666, K22 CA138563, U01 CA71966, R01 CA16056, K07 CA143047, U01 CA69417, R01-CA106414, R01 CA058860, R01 CA092044, PSA 042205, P30 CA14089, R01 CA61132, N01 PC67010]
  41. Cancer Research UK [16561] Funding Source: researchfish
  42. Cancer Research UK
  43. The Francis Crick Institute [10124] Funding Source: researchfish

Ask authors/readers for more resources

Cigarette smoking is associated with an increased risk of developing mucinous ovarian tumors but whether it is associated with ovarian cancer survival overall or for the different histotypes is unestablished. Furthermore, it is unknown whether the association between cigarette smoking and survival differs according to strata of ovarian cancer stage at diagnosis. In a large pooled analysis, we evaluated the association between various measures of cigarette smoking and survival among women with epithelial ovarian cancer. We obtained data from 19 case-control studies in the Ovarian Cancer Association Consortium (OCAC), including 9,114 women diagnosed with ovarian cancer. Cox regression models were used to estimate adjusted study-specific hazard ratios (HRs), which were combined into pooled hazard ratios (pHR) with corresponding 95% confidence intervals (CIs) under random effects models. Overall, 5,149 (57%) women died during a median follow-up period of 7.0 years. Among women diagnosed with ovarian cancer, both current (pHR=1.17, 95% CI: 1.08-1.28) and former smokers (pHR=1.10, 95% CI: 1.02-1.18) had worse survival compared with never smoking women. In histotype-stratified analyses, associations were observed for mucinous (current smoking: pHR=1.91, 95% CI: 1.01-3.65) and serous histotypes (current smoking: pHR=1.11, 95% CI: 1.00-1.23; former smoking: pHR=1.12, 95% CI: 1.04-1.20). Further, our results suggested that current smoking has a greater impact on survival among women with localized than disseminated disease. The identification of cigarette smoking as a modifiable factor associated with survival has potential clinical importance as a focus area to improve ovarian cancer prognosis. What's new? The number of female smokers is declining worldwide but an estimated 180 million women still smoke daily worldwide. Here the authors examined the association between cigarette smoking and ovarian cancer survival. Current and former smoking shortened survival compared to women who had never smoked, especially in those afflicted with mucinous and serous tumors and with localized disease. The study identifies cigarette smoking as a modifiable factor associated with ovarian cancer survival.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available